WO2010066437A3 - Composition aqueuse contenant du dexpanthénol et du chlorure de sodium - Google Patents

Composition aqueuse contenant du dexpanthénol et du chlorure de sodium Download PDF

Info

Publication number
WO2010066437A3
WO2010066437A3 PCT/EP2009/008855 EP2009008855W WO2010066437A3 WO 2010066437 A3 WO2010066437 A3 WO 2010066437A3 EP 2009008855 W EP2009008855 W EP 2009008855W WO 2010066437 A3 WO2010066437 A3 WO 2010066437A3
Authority
WO
WIPO (PCT)
Prior art keywords
sodium chloride
composition containing
aqueous composition
containing dexpanthenol
dexpanthenol
Prior art date
Application number
PCT/EP2009/008855
Other languages
German (de)
English (en)
Other versions
WO2010066437A2 (fr
Inventor
Max Werner Scheiwe
Henrik Von Wenckstern
Maria Genth
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of WO2010066437A2 publication Critical patent/WO2010066437A2/fr
Publication of WO2010066437A3 publication Critical patent/WO2010066437A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F03—MACHINES OR ENGINES FOR LIQUIDS; WIND, SPRING, OR WEIGHT MOTORS; PRODUCING MECHANICAL POWER OR A REACTIVE PROPULSIVE THRUST, NOT OTHERWISE PROVIDED FOR
    • F03D—WIND MOTORS
    • F03D9/00—Adaptations of wind motors for special use; Combinations of wind motors with apparatus driven thereby; Wind motors specially adapted for installation in particular locations
    • F03D9/20—Wind motors characterised by the driven apparatus
    • F03D9/22—Wind motors characterised by the driven apparatus the apparatus producing heat
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00—Energy generation through renewable energy sources
    • Y02E10/70—Wind energy
    • Y02E10/72—Wind turbines with rotation axis in wind direction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sustainable Energy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Power Engineering (AREA)
  • Sustainable Development (AREA)
  • Organic Chemistry (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur une composition pharmaceutique aqueuse contenant du dexpanthénol et du chlorure de sodium, caractérisée en ce que l'osmolalité de la composition est de 200 à 400 mosmol/kg, ainsi que sur son utilisation pour un produit médical destiné au traitement et/ou au soin de la muqueuse nasale. L'invention porte aussi sur un récipient contenant la composition aqueuse selon l'invention.
PCT/EP2009/008855 2008-12-12 2009-12-10 Composition aqueuse contenant du dexpanthénol et du chlorure de sodium WO2010066437A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE202008016517U DE202008016517U1 (de) 2008-12-12 2008-12-12 Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
DE202008016517.2 2008-12-12

Publications (2)

Publication Number Publication Date
WO2010066437A2 WO2010066437A2 (fr) 2010-06-17
WO2010066437A3 true WO2010066437A3 (fr) 2011-02-24

Family

ID=40418672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/008855 WO2010066437A2 (fr) 2008-12-12 2009-12-10 Composition aqueuse contenant du dexpanthénol et du chlorure de sodium

Country Status (2)

Country Link
DE (1) DE202008016517U1 (fr)
WO (1) WO2010066437A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
DE202012005650U1 (de) 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
DE202015104410U1 (de) * 2015-07-06 2016-07-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung von Rhinitis
DE202021103126U1 (de) 2021-06-09 2021-06-23 Alexander Leiser Wässrige Zusammensetzung für präventive medizinische Anwendungen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366888A1 (fr) * 1988-09-23 1990-05-09 CASSELLA Aktiengesellschaft Préparation pharmaceutique pour le traitement des inflammations des membranes muqueuses nasales
DE29807223U1 (de) * 1998-04-21 1998-09-17 Stada Arzneimittel Ag Pharmazeutische Zubereitung, umfassend Meerwasser und Pantothenol
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2010015253A1 (fr) * 2008-08-07 2010-02-11 Anna-Maria Vestweber Composition pharmaceutique pour application nasale

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366888A1 (fr) * 1988-09-23 1990-05-09 CASSELLA Aktiengesellschaft Préparation pharmaceutique pour le traitement des inflammations des membranes muqueuses nasales
DE29807223U1 (de) * 1998-04-21 1998-09-17 Stada Arzneimittel Ag Pharmazeutische Zubereitung, umfassend Meerwasser und Pantothenol
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2010015253A1 (fr) * 2008-08-07 2010-02-11 Anna-Maria Vestweber Composition pharmaceutique pour application nasale

Also Published As

Publication number Publication date
DE202008016517U1 (de) 2009-03-05
WO2010066437A2 (fr) 2010-06-17

Similar Documents

Publication Publication Date Title
TW200716208A (en) Modified and immediate release memantine bead formulation
MXPA05008909A (es) Formulacion intranasal de rotigotina.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
TW200800931A (en) Novel piperazines as antimalarial agents
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
WO2005082413A3 (fr) Combinaison de ciclesonide et de glycopyrronium
MX2019008489A (es) Tratamiento que comprende la administracion oral o gastrica de edaravona.
DE602008006700D1 (fr)
WO2010066437A3 (fr) Composition aqueuse contenant du dexpanthénol et du chlorure de sodium
WO2010090494A3 (fr) Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants
WO2008148573A3 (fr) Médicaments contenant une combinaison de principes actifs pour traiter les symptomes allergiques
MXPA05004535A (es) Unidad para dosificacion diaria de melatonina.
WO2005110413A3 (fr) Medicaments contenant des n-sulfamoyl-n'-arylpiperazines utilises pour la prophylaxie ou le traitement de l'obesite et des pathologies apparentees
WO2008003050A3 (fr) Formulations de nitrate de gallium
MA32635B1 (fr) Produit medicamenteux et traitement associe
MX357556B (es) Composiciones acuosas que comprenden arbekacina.
GB2446341A (en) Method and system for transdermal drug delivery
WO2011093818A3 (fr) Compositions pharmaceutiques comprenant du salmétérol et du fluticasone
CY1115266T1 (el) Φαρμακευτικες συνθεσεις αερολυματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
PL1915166T3 (pl) Marubina i kompozycja do ograniczania chrapania, opakowanie i sposób
EP2315589A4 (fr) PRODUIT PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET UN AGONISTE DES béta2-ADRÉNOCEPTEURS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09799024

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09799024

Country of ref document: EP

Kind code of ref document: A2